RecruitingPhase 4NCT05726136

Fluid Challenge and Plasma Volume, During Surgery

Comparison of Albumin and Ringer's Solution for Optimization of the Plasma Volume and Hemodynamics During Laparoscopic Surgery.


Sponsor

Joachim Zdolsek

Enrollment

60 participants

Start Date

Oct 23, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

A short bolus infusion of fluid, called "fluid challenge" is commonly recommended for fluid treatment during longer surgery. However a prolonged increase of the blood volume is a prerequisite to recommend the technique. The purpose with the study is to examine the plasma expanding effect of three different fluid challenge strategies (acetated Ringers 4 ml/kg body weight, albumin 5% 4 ml/kg body weight or albumin 20% 1 ml/kg body weight), using hemoglobin as a dilution indicator.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria5

  • Written consent to participate in the study
  • For women: relevant contraceptive, menopausal or a negative pregnancy test.
  • ASA category I to III
  • Laparoscopic abdominal surgery, with a duration of at least 90 minutes.
  • to 80 years

Exclusion Criteria6

  • Patients with known cardiac failure
  • \<18 or \>80 years
  • known allergy to albumin
  • extracellular hyperhydration or hypervolemia
  • kidney failure
  • pregnancy or planned pregnancy

Interventions

DRUGacetated Ringers

After insufflation of carbon dioxide during an abdominal laparoscopic procedure, the first fluid bolus is infused. Circulatory and volume effects are studied. If cardiac output increase a second bolus is infused and studied.

DRUGalbumin 5%

After insufflation of carbon dioxide during an abdominal laparoscopic procedure, the first bolus of fluid is infused. Circulatory and volume effects are studied. If cardiac output increases a second bolus is infused and studied.

DRUGalbumin 20%

After insufflation of carbon dioxide during an abdominal laparoscopic procedure, the first bolus of fluid is infused. Circulatory and volume effects are studied. If cardiac output increases a second bolus is infused and studied.


Locations(1)

Vrinnevi Hospital

Norrköping, Östergötland County, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05726136


Related Trials